Interestingly, the study also found that almost 3-in-10 study participants agreed that they are more accepting of ads when these ads are relevant to them, while about half feel neutral, and only 16% disagree.
The tough path to getting a drug to market was demonstrated Monday, as Pfizer Inc. said a highly anticipated potential treatment for Alzheimer's failed to reach its goals in a Phase 3study.
Ginkgo is a top-selling herb and has been hailed by some as a memory-booster, but the new University of Pittsburgh study found it didn't help prevent Alzheimer's or other forms of dementia in more than 3, 000 elderly study subjects.